Publication
Section 8 enforcement
Section 8 of the Clayton Act is having a resurgence, and life sciences companies should take notice.
Publication
Section 8 of the Clayton Act is having a resurgence, and life sciences companies should take notice.
Publication
As shown in recent cases, parties successfully have fought off merger challenges in court when they can show that the go...
Insights
Global businesses and their senior executives face significant domestic and cross border antitrust and competition issue...
Publication
Section 8 of the Clayton Act is having a resurgence, and life sciences companies should take notice.
Publication
As shown in recent cases, parties successfully have fought off merger challenges in court when they can show that the go...
© Norton Rose Fulbright LLP 2023